Yang, S., Liu, X., Yu, J., Liu, X., Zhao, S., Jiang, T., Yang, M., Wu, F., Sun, H., Li, A., Wang, L., Gao, G., Chen, X., Xu, Y., Chen, B., Ren, S. (2026). Ablation plus immunotherapy in advanced NSCLC patients who develop oligo-residual disease after anti–PD-1/L1 therapy: Updated results from the BOOSTER trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.8563